TCS CEO corrects three major Nashik facts: Nida Khan was not HR head, unit not shut, no POSH complaints on record
Read More Pharma Industry News Is this the most promising DLL3-targeting therapy yet? Zai Lab advances ADC into Phase 3 Zai Lab’s DLL3-targeting ADC for small cell lung cancer shows high brain metastasis activity; global Phase 3 trial now underway. Explore the data and future impact. byPallavi MadhirajuOctober 25, 2025